Tuesday, March 20, 2018 3:11:15 PM
Of course, both companies are operated by the same folks. And there seems to be some great synergy between the two. Although short term, they have to maintain a kind of "Chinese Firewall" between them for regulatory and legal reasons.
It makes sense to me to own both as I believe both have a gigantic opportunity before them. Since PAOG is lagging slightly behind RSII I think it is a better bargain right now.
With Trump's speech yesterday about moving to eliminate the opioid epidemic, I am thinking that PAO Group just might get the Dederal "spotlight" shined upon them soon. I have yet to find any other companies with such a concentrated focus on treatment.
All just my opinion...
Good Luck To All Longs.
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM